People: SIGA Technologies Inc (SIGA.O)

SIGA.O on Consolidated Issue listed on NASDAQ Global Market

2.79USD
17 Apr 2014
Price Change (% chg)

$-0.01 (-0.36%)
Prev Close
$2.80
Open
$2.81
Day's High
$2.89
Day's Low
$2.78
Volume
140,536
Avg. Vol
173,413
52-wk High
$4.15
52-wk Low
$2.72

Search Stocks

Rose, Eric 

Brief Biography

Dr. Eric A. Rose is Chairman of the Board, Chief Executive Officer of SIGA Technologies, Inc. He was elected Chairman of the Board of Directors on January 25, 2007, and, on March 1, 2007, became the Company’s Chief Executive Officer. Dr. Rose has served as a director of SIGA since April 19, 2001 and served as Interim Chief Executive Officer of SIGA during April-June 2001. Dr. Rose chaired the Department of Health Evidence & Policy at the Mount Sinai School of Medicine from 2008 to 2012, which he now serves as co-chair and professor. From 1994 through 2007, Dr. Rose served as Chairman of the Department of Surgery and Surgeon-in-Chief of the Columbia Presbyterian Center of New York Presbyterian Hospital. Dr. Rose is a former director of Abiomed, Inc., PharmaCore, Inc., TransTech Pharma, Inc., Nephros, Inc., Keryx Biopharmaceuticals, Inc. and Nexell Therapeutics Inc. Dr. Rose is a graduate of both Columbia College and Columbia University College of Physicians & Surgeons. In addition to his roles at SIGA, Dr. Rose holds a position as Executive Vice President – Life Sciences at MacAndrews & Forbes Holdings Inc. (“MacAndrews Holdings”), an affiliate of a SIGA shareholder.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
1,050,000 -- 202,136 1,846,140

Options Compensation

  Quantity Market Value
Exercisable 686,667 499,333.00
Unexercisable 533,333 --
Exercised 620,000 785,600.00
Name Fiscal Year Total

Eric Rose

1,846,140

Daniel Luckshire

901,277

William Haynes

643,008

Dennis Hruby

1,409,910

James Antal

--

Michael Bayer

--
As Of 30 Dec 2012
Search Stocks